Molecular Cytopathology Workshop
Tracking # 20-924332
$99999.00
There are no ratings for this course
Learn moreCourse overview
Cytology specimens undergo different preparation techniques from histologic tissue and therefore have unique limitations and applicability. Further, the limited volume nature of cytological specimens require judicious triaging and prioritization of specific molecular tests, based on the tumor type. As such, it is critical for practicing cytopathologists to understand the strengths and limitations of the various testing platforms for our unique specimen types. This course will provide essential skills for trainees and practicing pathologists to gain confidence in various aspects of molecular cytopathology. Through improved training in molecular pathology, cytopathologists can adequately triage specimens to expedite clinically actionable testing and be able to implement changes in their own practice to better utilize cytology specimens for molecular testing. The course provides organ-specific detailed molecular training, as well as general teaching on molecular assays and test selection. The course will empower cytopathologists to serve as experts in molecular cytopathology for both test selection and results interpretation. TARGET AUDIENCE This educational activity is designed for pathologists, fellows/residents, cytotechnologists, and other members of the cytopathology community. LEARNING OBJECTIVES Build confidence in molecular test ordering and interpretation Understand the cytology specimen types available for molecular testing Review common testing methodologies Understand organ-specific testing recommendations and limitations
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Clinical Laboratory Personnel
Clinical Laboratory Director
Clinical Laboratory Supervisor
Clinical Laboratory Technician
Clinical Laboratory Technologist
Public Health Director
Public Health Supervisor
Public Health Technician
Public Health Technologist
Disclosure statements
Maria D. Lozano, MD, PhD, MIACSpeaker: Roche, Pfizer, Astra Zeneca
Sinchita Roy-Chowdhuri, MD, PhD None
Giancarlo Troncone, MDAdvisor: Ely Lilly, Bristol Myers Squibb, GlaxoSmithKline
Paul VanderLaan, MD, PhD Consultant: Gala Therapeutics, Intuitive Surgical, Galvanize Therapeutics
Michiya Nishino, MD, PhD None
Michael J. Thrall, MD None
Aatur D. Singhi, MD, PhD Honorarium: Foundation Medicine
Ester Rossi, MD None
Vicki Jo, MD None
Chris VandenBussche, MD, PhD NCI SBIR Grant to Insitution: Thrive Early Detection, Advisor Board Member: Roche, Speaker Honorarium: Northwell Health
Vivian Weiss, MD, PhD None